Logo image of MGN.OL

MAGNORA ASA (MGN.OL) Stock Fundamental Analysis

OSL:MGN - Euronext Oslo - NO0010187032 - Common Stock - Currency: NOK

24.35  +0.7 (+2.96%)

Fundamental Rating

5

Overall MGN gets a fundamental rating of 5 out of 10. We evaluated MGN against 21 industry peers in the Independent Power and Renewable Electricity Producers industry. MGN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. MGN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

MGN had positive earnings in the past year.
In the past year MGN has reported a negative cash flow from operations.
MGN had positive earnings in 4 of the past 5 years.
In multiple years MGN reported negative operating cash flow during the last 5 years.
MGN.OL Yearly Net Income VS EBIT VS OCF VS FCFMGN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

MGN has a better Return On Assets (100.82%) than 100.00% of its industry peers.
MGN's Return On Equity of 137.85% is amongst the best of the industry. MGN outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 100.82%
ROE 137.85%
ROIC N/A
ROA(3y)45.75%
ROA(5y)25.52%
ROE(3y)62.41%
ROE(5y)34.96%
ROIC(3y)N/A
ROIC(5y)N/A
MGN.OL Yearly ROA, ROE, ROICMGN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

MGN has a better Profit Margin (25808.70%) than 100.00% of its industry peers.
In the last couple of years the Profit Margin of MGN has grown nicely.
MGN does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 25808.7%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y250.83%
GM growth 3YN/A
GM growth 5YN/A
MGN.OL Yearly Profit, Operating, Gross MarginsMGN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K 20K 25K

More info and screens

7

2. Health

2.1 Basic Checks

MGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
MGN has less shares outstanding than it did 1 year ago.
MGN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MGN is higher compared to a year ago.
MGN.OL Yearly Shares OutstandingMGN.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MGN.OL Yearly Total Debt VS Total AssetsMGN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

MGN has an Altman-Z score of 6.16. This indicates that MGN is financially healthy and has little risk of bankruptcy at the moment.
MGN's Altman-Z score of 6.16 is amongst the best of the industry. MGN outperforms 100.00% of its industry peers.
MGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.16
ROIC/WACCN/A
WACC8.54%
MGN.OL Yearly LT Debt VS Equity VS FCFMGN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 1.94 indicates that MGN should not have too much problems paying its short term obligations.
MGN has a Current ratio of 1.94. This is in the better half of the industry: MGN outperforms 76.19% of its industry peers.
MGN has a Quick Ratio of 1.94. This is a normal value and indicates that MGN is financially healthy and should not expect problems in meeting its short term obligations.
MGN has a Quick ratio of 1.94. This is in the better half of the industry: MGN outperforms 76.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.94
MGN.OL Yearly Current Assets VS Current LiabilitesMGN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

MGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.58%, which is quite impressive.
Measured over the past years, MGN shows a very strong growth in Earnings Per Share. The EPS has been growing by 87.45% on average per year.
The Revenue for MGN has decreased by -80.99% in the past year. This is quite bad
The Revenue for MGN have been decreasing by -43.96% on average. This is quite bad
EPS 1Y (TTM)87.58%
EPS 3YN/A
EPS 5Y87.45%
EPS Q2Q%3150%
Revenue 1Y (TTM)-80.99%
Revenue growth 3Y-46.71%
Revenue growth 5Y-43.96%
Sales Q2Q%311.18%

3.2 Future

MGN is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.93% yearly.
The Revenue is expected to decrease by -0.81% on average over the next years.
EPS Next Y-21.58%
EPS Next 2Y28.37%
EPS Next 3Y-3.93%
EPS Next 5YN/A
Revenue Next Year-8.07%
Revenue Next 2Y1.5%
Revenue Next 3Y-0.81%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MGN.OL Yearly Revenue VS EstimatesMGN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
MGN.OL Yearly EPS VS EstimatesMGN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.05, the valuation of MGN can be described as very cheap.
MGN's Price/Earnings ratio is rather cheap when compared to the industry. MGN is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.32. MGN is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 3.53 indicates a rather cheap valuation of MGN.
100.00% of the companies in the same industry are more expensive than MGN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, MGN is valued rather cheaply.
Industry RankSector Rank
PE 5.05
Fwd PE 3.53
MGN.OL Price Earnings VS Forward Price EarningsMGN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MGN.OL Per share dataMGN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A cheap valuation may be justified as MGN's earnings are expected to decrease with -3.93% in the coming years.
PEG (NY)N/A
PEG (5Y)0.06
EPS Next 2Y28.37%
EPS Next 3Y-3.93%

More info and screens

0

5. Dividend

5.1 Amount

MGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAGNORA ASA

OSL:MGN (6/16/2025, 2:26:58 PM)

24.35

+0.7 (+2.96%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)04-25 2025-04-25/bmo
Earnings (Next)07-18 2025-07-18
Inst Owners13.43%
Inst Owner ChangeN/A
Ins Owners5.81%
Ins Owner ChangeN/A
Market Cap1.60B
Analysts86.67
Price Target38.08 (56.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend4.62
Dividend Growth(5Y)0.46%
DP50.45%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)665.84%
Min EPS beat(2)-78.22%
Max EPS beat(2)1409.9%
EPS beat(4)2
Avg EPS beat(4)338.72%
Min EPS beat(4)-78.22%
Max EPS beat(4)1409.9%
EPS beat(8)2
Avg EPS beat(8)86.98%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)67.51%
Min Revenue beat(2)16.06%
Max Revenue beat(2)118.97%
Revenue beat(4)4
Avg Revenue beat(4)50.1%
Min Revenue beat(4)16.06%
Max Revenue beat(4)118.97%
Revenue beat(8)5
Avg Revenue beat(8)18.35%
Revenue beat(12)8
Avg Revenue beat(12)276.38%
Revenue beat(16)10
Avg Revenue beat(16)233.28%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)92.86%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)13.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)15.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)25.13%
Valuation
Industry RankSector Rank
PE 5.05
Fwd PE 3.53
P/S 696.41
P/FCF N/A
P/OCF N/A
P/B 3.72
P/tB 5.73
EV/EBITDA N/A
EPS(TTM)4.82
EY19.79%
EPS(NY)6.9
Fwd EY28.33%
FCF(TTM)-1.49
FCFYN/A
OCF(TTM)-1.49
OCFYN/A
SpS0.03
BVpS6.55
TBVpS4.25
PEG (NY)N/A
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 100.82%
ROE 137.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 25808.7%
GM N/A
FCFM N/A
ROA(3y)45.75%
ROA(5y)25.52%
ROE(3y)62.41%
ROE(5y)34.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y250.83%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.09%
Cap/Sales 4.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.94
Altman-Z 6.16
F-Score4
WACC8.54%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)19.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.58%
EPS 3YN/A
EPS 5Y87.45%
EPS Q2Q%3150%
EPS Next Y-21.58%
EPS Next 2Y28.37%
EPS Next 3Y-3.93%
EPS Next 5YN/A
Revenue 1Y (TTM)-80.99%
Revenue growth 3Y-46.71%
Revenue growth 5Y-43.96%
Sales Q2Q%311.18%
Revenue Next Year-8.07%
Revenue Next 2Y1.5%
Revenue Next 3Y-0.81%
Revenue Next 5YN/A
EBIT growth 1Y75.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-12.61%
EBIT Next 3Y-6.29%
EBIT Next 5YN/A
FCF growth 1Y-252.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-535.07%
OCF growth 3YN/A
OCF growth 5YN/A